Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Array Biopharma Inc (NASDAQ:ARRY)

5.94
Delayed Data
As of Aug 28
 +0.10 / +1.71%
Today’s Change
2.98
Today|||52-Week Range
8.59
+25.58%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
AssetsCash55.8M60.7M68.6M--
 
 
 
 
Short Term Investment Cash7.7M4.9M7.9M--
 
 
 
 
Cash & Short Term Investments89.2M108.2M111.0M--
 
 
 
 
 
ReceivablesReceivables950.0K9.6M5.4M--
 
 
 
 
 
InventoriesInventories0.00--------
 
Current AssetsOther Current Assets3.0M3.5M5.2M185.1M
 
 
 
 
 
Current Assets93.1M121.3M121.7M185.1M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross86.3M88.5M90.4M58.4M
 
 
 
 
 
Depreciation-74.2M-78.5M-82.3M--
 
 
 
 
Other Assets2.4M4.2M8.6M--
 
 
 
 
Total Assets108.1M136.0M139.1M198.2M
 
 
 
 
 
 
LiabilitiesAccounts Payable6.5M5.4M7.0M--
 
 
 
 
Short Term Debt150.0K0.000.00--
 
 
Accrued Expenses6.8M6.7M11.5M--
 
 
 
 
Other Current Liabilities61.8M35.7M37.6M--
 
 
 
 
Other Liabilities75.9M50.6M52.7M--
 
 
 
 
 
Total LiabilitiesLong Term Debt92.1M99.0M104.0M107.3M
 
 
 
 
 
Other Liabilities1.1M465.0K640.0K0.00
 
 
 
 
Total Liabilities193.9M157.9M164.8M107.3M
 
 
 
 
 
 
EquityMinority Interest0.000.000.00----
Preferred Stock8.1M0.000.00--
 
 
Common Equity-93.9M-21.9M-25.7M42.7M
 
 
 
 
 
Total Shareholder Equity-85.8M-21.9M-25.7M42.7M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding92.1M116.9M131.8M--
 
 
 
 
 
Addtl. Info.No data currently available for this section.